RxSight, Inc. SEC filings RXST

RxSight, Inc. has 474 filings in SEC EDGAR's recent list, going back to Jul 30, 2002. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

RxSight, Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Apr 27, 2026
DEF 14A Proxy statement Apr 21, 2025 Apr 21, 2025
DEFA14A Additional proxy material Apr 21, 2025 —
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Apr 25, 2024
DEFA14A Additional proxy material Apr 20, 2023 —
DEF 14A Proxy statement Apr 20, 2023 Jun 1, 2023
PRE 14A Preliminary proxy statement Apr 10, 2023 Jun 1, 2023
DEFA14A Additional proxy material Apr 21, 2022 —
DEF 14A Proxy statement Apr 21, 2022 Jun 2, 2022

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Ophthalmic Goods (SIC 3851)
Listed as
RXST (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Aliso Viejo, CA
SEC filer status
Accelerated filer
SEC CIK
1111485
Former names
CALHOUN VISION INC (until Mar 20, 2014)

Other Ophthalmic Goods companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.